Wiggin and Dana Ranked in BioPharm Insight's Licensing League Tables

April 14, 2015

Stamford – Wiggin and Dana is pleased to announce that its Biotechnology and Life Sciences practice has ranked in BioPharm Insight's 2014 Licensing League Tables. The firm has consistently ranked as a top 10 Global Law Firm in the Licensing League Tables since 2011.

Wiggin and Dana received the following rankings from BioPharm Insight in 2014:

  • 9th – Global: Legal Advisers to Biotech and Pharma Licensing Agreements – Based upon Volume – (8 deals)

  • 10th - North America: Legal Advisers to Biotech and Pharma Licensing Agreements – Based upon Value – ($444 Million)
  • 4th – Europe: Legal Advisers to Biotech and Pharma Licensing Agreements – Based upon Volume – (8 deals)


A complete copy of the Licensing League Tables can be found by clicking here.

BioPharm Insight is a market provider of information and coverage of global drug licensing deals as they take place. It publishes quarterly league tables to rank licensing activity in the life sciences industry, based on pharmaceutical drug licensing agreements announced during the period. The league tables are based on dominant geography of either licensor or licensee. For more information, please visit www.biopharminsight.com.